Evidence map›Paper›PMID 28594912›Full record

ArticlePloS one2017

Cancer cell redirection biomarker discovery using a mutual information approach.

Kimberly Roche, F Alex Feltus, Jang Pyo Park, Marie-May Coissieux, Chenyan Chang, Vera B S Chan, Mohamed Bentires-Alj, Brian W Booth

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Tumor-treating fields and concurrent cisplatin: anAmerican journal of cancer research · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Redirecting Normal and Cancer Stem Cells to a Mammary Epithelial Cell Fate.Journal of mammary gland biology and neoplasia · 2019
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kimberly RocheDepartment of Genetics and Biochemistry, Clemson University, Clemson, South Carolina, United States of America.
F Alex FeltusDepartment of Genetics and Biochemistry, Clemson University, Clemson, South Carolina, United States of America.
Jang Pyo ParkInstitute for Biological Interfaces of Engineering, Clemson University, Clemson, South Carolina, United States of America.
Marie-May CoissieuxDepartment of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.
Chenyan ChangDepartment of Genetics and Biochemistry, Clemson University, Clemson, South Carolina, United States of America.
Vera B S ChanDepartment of Biological Sciences, Clemson University, Clemson, South Carolina, United States of America.
Mohamed Bentires-AljDepartment of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.
Brian W BoothInstitute for Biological Interfaces of Engineering, Clemson University, Clemson, South Carolina, United States of America.ORCID http://orcid.org/0000-0003-2542-7302

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introducing tumor-derived cells into normal mammary stem cell niches at a sufficiently high ratio of normal to tumorous cells causes those tumor cells to undergo a change to normal mammary phenotype and yield normal mammary progeny. This phenomenon has been termed cancer cell redirection. We have developed an in vitro model that mimics in vivo redirection of cancer cells by the normal mammary microenvironment. Using the RNA profiling data from this cellular model, we examined high-level characteristics of the normal, redirected, and tumor transcriptomes and found the global expression profiles clearly distinguish the three expression states. To identify potential redirection biomarkers that cause the redirected state to shift toward the normal expression pattern, we used mutual information relationships between normal, redirected, and tumor cell groups. Mutual information relationship analysis reduced a dataset of over 35,000 gene expression measurements spread over 13,000 curated gene sets to a set of 20 significant molecular signatures totaling 906 unique loci. Several of these molecular signatures are hallmark drivers of the tumor state. Using differential expression as a guide, we further refined the gene set to 120 core redirection biomarker genes. The expression levels of these core biomarkers are sufficient to make the normal and redirected gene expression states indistinguishable from each other but radically different from the tumor state.

Indexed as

Models, BiologicalAnimalsBiomarkers, TumorCell Line, TumorFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticMammary Neoplasms, AnimalMiceBiomarkers, Tumor

Identifiers

PMID28594912
PMCPMC5464651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.